AC
VANI icon

Ascend Capital’s Vivani Medical VANI Stock Holding History

Ascend Capital’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-417
Closed -$128K – 197
2015
Q1 		$128K Buy
+417
New +$116K ﹤0.01% 162

Other funds holding VANI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BL
Bolton LP Greenwich, Connecticut $259M AUM 30.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Ascend Capital's VANI Position: Q2 2015 in Review

Ascend Capital sold out of Vivani Medical (VANI) in Q2 2015, closing a stake of 417 shares — an estimated $128K sold.

Ascend Capital first reported a position in VANI in Q1 2015 and held it in 1 quarter. The position peaked at $128K in Q1 2015. 50 funds tracked by Wall St. Rank hold VANI as of Q2 2015.

  • Ascend Capital reported no remaining Vivani Medical position as of Q2 2015 after selling out during the quarter.
  • Ascend Capital sold 417 Vivani Medical shares in Q2 2015, an estimated $128K.
  • Ascend Capital first reported a position in Vivani Medical in Q1 2015 and held it in 1 quarter.
  • Ascend Capital's Vivani Medical position peaked at $128K in Q1 2015.
  • 50 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2015.

Based on Ascend Capital's 13F filing for Q2 2015, filed 13 Aug 2015.